AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease
Lulu Zhang(Beijing University of Chinese Medicine), Qi Wang(Beijing University of Chinese Medicine), Mingyan Shao(Beijing University of Chinese Medicine), Lingru Li(Beijing University of Chinese Medicine), Yanfei Zheng(Beijing University of Chinese Medicine), Meiyi Liu(Beijing University of Chinese Medicine), Dong Yang(China Energy Science and Technology Research Institute Co., Ltd. (China)), Yini Fang(Beijing University of Chinese Medicine), Wenlong Sun(Shandong University of Technology), Juan Feng(Beijing University of Chinese Medicine), Hui Luo(Sun Yat-sen University), Shipeng Zhao(Beijing University of Chinese Medicine), Aiping Chen(Beijing University of Chinese Medicine), Yi Zheng(Beijing University of Chinese Medicine), Tianxing Li(Shandong University of Technology)
Cited by 19
Related Papers
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
|Nature Medicine|2024|162
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
|BMC Cancer|2015|160
Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota
|Cell Reports|2021|120